I'm a Group Leader in the Analytical Development group for CMC. At Evox we're developing next generation therapeutics using Exosomes either directly as a therapeutic or as a delivery mechanism. We're excited to be investing in new technologies to allow us to overcome the challenges of working with a novel and complex biological therapeutic.
Presentation Title: Building Analytical Outsourcing Process for New Modality Therapeutics